Theraptosis

About:

Theraptosis is a biopharmaceutical company that designs and develops various drugs for cancer and neurodegenerative diseases.

Top Investors: Auriga Partners

Description:

Theraptosis is a biopharmaceutical company that designs and develops various drugs for cancer and neurodegenerative diseases. It also offers research and development programs covering anti-angiogenesis, targeted tumor cell killing, auto-immunity, and neuroprotection. Theraptosis was founded in 2001 and is based in Romainville, France.